Advertisement
News
Subscribe to MDT Magazine News

PCC Frustrated with Payers' Lack of 5010 Readiness

April 19, 2011 11:37 am | by Bio-Medicine.Org | Comments

WINOOSKI, Vt., April 19, 2011 /- Physician's Computer Company (PCC) – a Vermont pediatric software developer that is ready to begin full production of the updated 5010 transaction standard for electronic claims and claims status – is frustrated by a lack of readiness among its...

TOPICS:

Biogen's 'Avonex Pen' MS treatment moves toward EU approval

April 19, 2011 10:40 am | by Mass High Tech: The Journal of New England Technology | Comments

Biogen Idec, a biotechnology company best known for its blockbuster multiple sclerosis treatments, has announced that a European regulatory panel has given a positive recommendation to a new self-administered form of its Avonex MS drug.

TOPICS:

Pelvic-repair device developed by UT Southwestern surgeons enables minimally invasive trauma surgery

April 19, 2011 10:40 am | by EurekAlert | Comments

(UT Southwestern Medical Center) A device developed by UT Southwestern Medical Center surgeons offers precise repair of pelvic fractures with minimal post-surgical scarring, pain and infection risk and is available for broad adoption by the nation's 200 level I trauma centers.

TOPICS:
Advertisement

Ruggieri to lead Dynasil as president

April 19, 2011 10:39 am | by Mass High Tech: The Journal of New England Technology | Comments

Dynasil Inc. has named Stene Ruggieri as president of the Watertown photonics manufacturer for instruments, optical materials, coatings and components. He takes over the position from Craig Dunham, who is retiring from the role.

Genzyme Genetics reported to lay off 169

April 19, 2011 10:39 am | by Mass High Tech: The Journal of New England Technology | Comments

Genzyme Genetics, the genetics testing business sold by Genzyme in September to Laboratory Corporation of America, has announced layoffs of 169 employees, including staff at its Westborough location, according to a Worcester Business Journal report.

FDA CONSUMER HEALTH INFORMATION - FDA Acts to Reduce Opioid Abuse

April 19, 2011 10:38 am | by Bio-Medicine.Org | Comments

SILVER SPRING, Md., April 19, 2011 /PRNewswire-USNewswire/ -- The Food and Drug Administration says 12 brand name medications are at the root of misuse, misprescribing, abuse, overdoses, addiction, and even deaths across the U.S. Are you taking one of these powerful opioids? (Logo:...

TOPICS:

Sangart Announces Closing of $50 Million Series G Financing

April 19, 2011 10:38 am | by Bio-Medicine.Org | Comments

SAN DIEGO, April 19, 2011 /- Sangart, Inc., today announced that it recently received more than $50 million in new equity funding from existing investors, led by Leucadia National Corporation. The most recent investment brings the total funding raised by the company since its inception in...

TOPICS:

Molina Healthcare moves higher as 1Q profit climbs

April 19, 2011 9:45 am | by The Associated Press | Comments

Shares of health insurer Molina Healthcare Inc. rose Tuesday after the company said its net income rose 64 percent in the first quarter as its premium revenue grew, and it spent a smaller portion of its revenue on medical care.Molina said its profit increased to $17.4 million, or 56 cents per...

Advertisement

Earnings Preview: UnitedHealth reports 1Q earnings

April 19, 2011 9:45 am | by The Associated Press | Comments

Managed care company UnitedHealth Group Inc. becomes the first major health insurer to report first-quarter earnings when it releases results Thursday before the market opens.WHAT TO WATCH FOR: Health insurers finished strong in 2010, as a slowdown in care use helped companies beat analyst...

Pratt & Whitney and Micro Engineering Solutions Experts Announced as EASTEC 2011 Keynotes

April 19, 2011 8:41 am | by Society of Manufacturing Engineers | Comments

WEST SPRINGFIELD, MA (April 19, 2011) — EASTEC 2011, the largest annual manufacturing event on the East Coast, has announced its keynote speakers for the May 17–19 event held at the Eastern States Exposition in West Springfield, MA. More

AstraZeneca Sued Over Alleged Nexium Injuries, According to The Gibson Law Firm

April 19, 2011 8:39 am | by Bio-Medicine.Org | Comments

HOUSTON, April 19, 2011 /- An Ohio woman suffered bone deterioration and broken bones because of hidden risks with pharmaceutical giant AstraZeneca's acid reflux drug Nexium,  The Gibson Law Firm alleges in a lawsuit filed today in Texas federal court. Filed in...

TOPICS:

New Class of Instruments for Flexible Surgery from Apollo Endosurgery® Used in Cancer Therapy

April 19, 2011 8:39 am | by Bio-Medicine.Org | Comments

AUSTIN, Texas, April 19, 2011 /- Florida Hospital Celebration Health announced this week the use of a new class of flexible surgical instruments created by Apollo Endosurgery®, to remove a stomach tumor and extract it through the patient's mouth. Following the two-hour surgery, the...

TOPICS:

Masimo to Report First Quarter 2011 Financial Results After Market Close on May 3, 2011

April 19, 2011 8:39 am | by Bio-Medicine.Org | Comments

IRVINE, Calif., April 19, 2011 /- Masimo (NASDAQ: MASI ) announced today that it will release first quarter financial results for the period ended April 2, 2011, after the market closes on May 3, 2011. A conference call to review the results will begin at 1:30 p.m. PT (4:30 p.m. ET) and...

TOPICS:

Amira Pharmaceuticals Receives Orphan Drug Status for a Novel LPA1 Antagonist, AM152, for the Treatment of Idiopathic Pulmonary Fibrosis

April 19, 2011 8:37 am | by Bio-Medicine.Org | Comments

SAN DIEGO, April 19, 2011 /- Amira Pharmaceuticals, Inc. announced today that AM152, the company's lead LPA1 antagonist, has been granted an orphan drug designation by the U.S. Food and Drug Administration for the treatment of idiopathic pulmonary fibrosis. Commonly referred to as IPF,...

TOPICS:

Steris System 1 Processor: 6 Month Extension for Healthcare Facilities To Transition to Legally-Marketed Alternatives

April 19, 2011 8:30 am | by U.S. Food & Drug Administration | Comments

FDA has extended the transition period to February 2, 2012. All healthcare facilities must be transitioned from Steris Corporation?s modified System 1 processor (SS1) to legally-marketed alternative devices by that time.

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading